Independent Verification
Ascend Peptides UK
Independently Verified
Companies House 17036171 · active · incorporated 16 Feb 2026
Trust Index score (unaffected either way)
95/100 A+
Where this stands
A digital evidence assessment was completed against all 8 categories of PeptideClear's Independent Verification methodology. 4 material findings were identified and put to Ascend Peptides UK on 18 August 2026. Ascend corrected all 4 and PeptideClear independently re-checked each one live on the retailer's own site, rather than accepting the retailer's word for it, with every correction confirmed live within 24 hours of being raised. Nothing material remains unresolved.
Catalogue coverage
Live catalogue
26 products
CoA-linked to a distinct report
12/26 · 46%
Independently verified live
4/26 · 15%
Batch identifier unique to product
0/26 · 0%
Marketed as tested, no matching CoA
7/26 · 27%
Findings raised, resolved during review
4 material findings were put to Ascend Peptides UK under the right-of-reply process. All 4 were corrected and independently re-verified live before publication, rather than accepted on the retailer's word. Each carries an evidence-strength rating (A = verified at the source itself, down to E = unable to establish), see the methodology for the full scale.
Accreditation claimed and independently confirmable
Ascend's FAQ ("Which analytical methods do you routinely use?") stated "All analyses are conducted by accredited third-party laboratories." Janoshik makes no accreditation claim on its own site, and a direct search of the Czech Accreditation Institute's register (the correct body, since Janoshik is Czech-registered) returned zero results.
Czech Accreditation Institute register search
Resolution
The unsupported accreditation claim was removed and replaced with "independent third-party laboratories", which is accurate and independently confirmed elsewhere in this review. Verified live, 19 August 2026.
Catalogue-wide traceability coverage
7 of 26 products (27%) were marketed as "tested by Janoshik, HPLC ≥98%" with no matching CoA linked anywhere on the site: AOD-9604 10mg, AOD-9604 5mg, GHK-CU 50mg, Ipamorelin 5mg, MOTS-C 10mg, Sermorelin 2mg, Tesamorelin 5mg.
ascendpeptidesuk.com/shop/ (26 products) + /coas/
Resolution
The unsupported testing claim was removed from all products checked. Verified live on 3 of the 7 named product pages, 18 August 2026.
Expert/practitioner endorsement disclosure
"Scientific content reviewed by an MBBS-qualified medical reviewer" recurred as templated text across multiple pages, with no name, no GMC/registration number, and no disclosed financial relationship to Ascend.
e.g. ascendpeptidesuk.com/what-is-ghk-cu/, /what-is-bpc-157/, /how-we-test-peptides/
Resolution
The unverifiable reviewer credential line was removed sitewide. Verified live across all pages originally flagged, 19 August 2026.
Population/route/dose match for cited studies
The CJC-1295 product page's headline potency claim (a "5.8–8.1 day half-life") was sourced from human-subject subcutaneous-injection clinical trials, on a product marketed as "for in-vitro laboratory research only. Not for human consumption."
Teichman et al. 2006, JCEM 91(3):799-805; Ionescu & Frohman 2006, JCEM
Resolution
The figure is now explicitly attributed to the published Teichman et al. (2006) study population rather than presented as a product-performance claim, with the Research Use Only framing retained. Verified live, 18 August 2026.
Additional items
Recorded for completeness. None of these are material enough on their own to affect the headline result.
Unique batch/lot identifiers
All 4 directly-checked reports (different compounds) share the identical batch code "20260114", reading as one shipment/submission code, not a per-product lot number. 0% of the catalogue has a batch identifier unique to that specific product.
Registered address type
Registered office (71–75 Shelton Street) is a mass company-formation address (1st Formations Ltd's registered-office service), shared with thousands of unrelated companies. Not disclosed anywhere on Ascend's own site.
Named human contact / data controller
No Companies House number, VAT number, or registered address found anywhere on the site (privacy policy, T&Cs, contact, or about page), only "Registered in England" plus an email and phone number. No named human behind the business.
Consistency of eligibility policy
T&Cs use pure self-attestation (18+, research-purpose checkbox). FAQ states buyers "may be required to confirm research credentials... supporting documentation." Two different gating mechanisms described; which actually operates at checkout could not be determined without transacting.
Age-restriction handling in the purchase path
18+ statement found on only 3 of 32 policy pages, and on none of the 26 product pages or the homepage: a customer can browse and price every product with no age gate in the actual purchase path.
Citation accuracy
3 of 19 citations carry factual errors (wrong PMID for Malinda 1999, wrong year for Campbell [1994, cited as 1991], wrong journal for Soos 1993 [Biochemical Journal, cited as JBC]), reading as sloppy citation management, not invention.
Confirmed clean
Payment buys the assessment, not the result. What checked out is published with the same weight as what didn't.
- ✓Janoshik is a genuine, separately-registered Czech company (ICO 17668727), a fully separate legal entity from Ascend.
- ✓Janoshik's own report-verification system works: 4 CoA links tested live, all resolved to genuine reports on the lab's own domain (verify.janoshik.com).
- ✓CoAs report real quantitative results (e.g. purity to 3 decimal places), not a template pass/fail.
- ✓Of 19 study citations checked, the large majority are genuinely real papers, not fabricated: a positive, not the default in this category.
- ✓RUO / no-MHRA-approval framing is the most consistent element of the site, present on all 77 pages checked.
- ✓BPC-157 product and guide pages carry the most honest evidence-limitation language found anywhere on the site.
- ✓No testimonials exist on the site to be fake or undisclosed.
- ✓Companies House record is clean: active, no strike-off notices, no Gazette filings, sole director has no other current or dissolved company history.
- ✓No relevant MHRA, ASA, or Trading Standards public record identified in the sources searched, as of 18 August 2026.
- ✓No explicit human-use product formats (capsules, pens, sprays) found. All 26 SKUs sold as lyophilised powder.
Audit trail
| Step | Date | Detail |
|---|---|---|
| Independent Verification completed | 18 Aug 2026 | All 8 categories reviewed against publicly accessible digital sources. |
| Findings put to retailer | 18 Aug 2026 | 4 material findings sent directly to Ascend Peptides UK, with an invitation to provide any evidence that resolves them. |
| Retailer response | 18-19 Aug 2026 | Retailer made changes addressing all 4 findings across two rounds of correction. |
| Independent re-verification | 19 Aug 2026 | Each change checked live on the retailer's own site rather than accepted on their word. All 4 confirmed resolved. |